← Leaderboards
Brian Robert Krause
Alphacore Pharma, Llc
$1,494,429
Attributed
$1,494,429
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2008–11$2M$1.5M$1M$500K$0
'08
'09
'10
'11
Funding mix
By agency
NIH$1,494,429 · 2
By mechanism
R44$1,254,300 · 1
R43$240,129 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Esterification”
- Ta-Yuan Chang · Dartmouth College$7,435,877
- Ronald T Raines · Massachusetts Institute Of Technology$6,404,558
- E Douglas Lewandowski · Ohio State University$5,564,914
- Peter J Tontonoz · University Of California Los Angeles$4,808,118
- Richard W Hanson · Case Western Reserve University$4,330,931
- Daniel James Rader · University Of Pennsylvania$3,972,724
Research focus
EsterificationExcretory FunctionCoronary Heart DiseaseEnzymesEventExcisionCoronaryAmericanDietDoseCarrier ProteinsClinical TrialsCholesterolCholesterol EstersArterial Fatty StreakAcute Coronary SyndromeArteriesAtherosclerosisAnimal ModelBile FluidAnimalsBlood FlowAcuteFunding
Grant awards (3)
Treatment of Acute Coronary Syndromes with Recombinant LCAT Infusion$231,470
R44 · FY2011 · HL · contact PI
Treatment of Acute Coronary Syndromes with Recombinant LCAT Infusion$1,022,830
R44 · FY2010 · HL · contact PI
The Use of LCAT Infusion to Treat Acute Coronary Syndromes$240,129
R43 · FY2008 · HL · contact PI